$DUKR

2023 Q2 Form 10-Q Financial Statement

#000121390023037670 Filed on May 09, 2023

View on sec.gov

Income Statement

Concept 2023 Q2 2023 Q1 2022 Q1
Revenue $0.00 $0.00
YoY Change -100.0%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $206.0K $331.0K
YoY Change -37.0% 105.59%
% of Gross Profit
Research & Development $6.000K
YoY Change
% of Gross Profit
Depreciation & Amortization $2.000K $0.00
YoY Change -100.0%
% of Gross Profit
Operating Expenses $0.00 $0.00 $337.0K
YoY Change -100.0% -100.0%
Operating Profit -$206.0K -$202.0K -$337.0K
YoY Change -37.58% -40.06% -167.4%
Interest Expense $23.00K -$32.00K
YoY Change -46.51% -85.45%
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income -$183.0K -$369.0K
YoY Change -36.24% -247.01%
Income Tax
% Of Pretax Income
Net Earnings -$183.0K -$179.0K -$369.0K
YoY Change -36.24% -51.49% -247.01%
Net Earnings / Revenue
Basic Earnings Per Share $0.00 $0.00 -$0.01
Diluted Earnings Per Share $0.00 $0.00 -$6.829K
COMMON SHARES
Basic Shares Outstanding 54.22M shares 54.22M shares 54.03M shares
Diluted Shares Outstanding 54.56M shares 54.49M shares 54.03M shares

Balance Sheet

Concept 2023 Q2 2023 Q1 2022 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $2.621M $3.415M
YoY Change -23.25% 655.53%
Cash & Equivalents $2.419M $2.621M $3.415M
Short-Term Investments
Other Short-Term Assets $258.0K $167.0K $28.00K
YoY Change 396.15% 496.43% -49.09%
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $2.677M $2.788M $3.443M
YoY Change -16.5% -19.02% 579.09%
LONG-TERM ASSETS
Property, Plant & Equipment $54.00K $56.00K $21.00K
YoY Change 134.78% 166.67% 90.91%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $152.0K
YoY Change
Total Long-Term Assets $194.0K $208.0K $21.00K
YoY Change 410.53% 890.48% 90.91%
TOTAL ASSETS
Total Short-Term Assets $2.677M $2.788M $3.443M
Total Long-Term Assets $194.0K $208.0K $21.00K
Total Assets $2.871M $2.996M $3.464M
YoY Change -11.5% -13.51% 568.73%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $77.00K $87.00K $76.00K
YoY Change 0.0% 14.47% -68.07%
Accrued Expenses $236.0K $177.0K
YoY Change 33.33%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $358.0K $323.0K $253.0K
YoY Change 104.57% 27.67% -78.99%
LONG-TERM LIABILITIES
Long-Term Debt $307.0K $299.0K
YoY Change 2.68% -37.97%
Other Long-Term Liabilities $80.00K
YoY Change
Total Long-Term Liabilities $387.0K $299.0K
YoY Change 29.43% -43.48%
TOTAL LIABILITIES
Total Short-Term Liabilities $358.0K $323.0K $253.0K
Total Long-Term Liabilities $387.0K $299.0K
Total Liabilities $734.0K $710.0K $552.0K
YoY Change 54.2% 28.62% -68.15%
SHAREHOLDERS EQUITY
Retained Earnings -$9.378M -$9.195M
YoY Change 40.49%
Common Stock $5.000K $5.000K
YoY Change 0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $2.137M $2.286M $2.912M
YoY Change
Total Liabilities & Shareholders Equity $2.871M $2.996M $3.464M
YoY Change -11.5% -13.51% 568.73%

Cashflow Statement

Concept 2023 Q2 2023 Q1 2022 Q1
OPERATING ACTIVITIES
Net Income -$183.0K -$179.0K -$369.0K
YoY Change -36.24% -51.49% -247.01%
Depreciation, Depletion And Amortization $2.000K $0.00
YoY Change -100.0%
Cash From Operating Activities -$209.0K -$133.0K
YoY Change 57.14% -137.68%
INVESTING ACTIVITIES
Capital Expenditures $16.00K -$12.00K
YoY Change -233.33%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities -$16.00K -$12.00K
YoY Change 33.33%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities
YoY Change
NET CHANGE
Cash From Operating Activities -$209.0K -133.0K
Cash From Investing Activities -$16.00K -12.00K
Cash From Financing Activities
Net Change In Cash -$228.0K $0.00
YoY Change
FREE CASH FLOW
Cash From Operating Activities -$209.0K -$133.0K
Capital Expenditures $16.00K -$12.00K
Free Cash Flow -$225.0K -$121.0K
YoY Change 85.95% -134.28%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q1 dei Document Type
DocumentType
10-Q
CY2023Q1 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2023Q1 dei Document Period End Date
DocumentPeriodEndDate
2023-03-31
CY2023Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
CY2023Q1 dei Document Transition Report
DocumentTransitionReport
false
CY2023Q1 dei Entity File Number
EntityFileNumber
000-55504
CY2023Q1 dei Entity Registrant Name
EntityRegistrantName
UAS Drone Corp.
CY2023Q1 dei Entity Address City Or Town
EntityAddressCityOrTown
Tirat-Carmel
CY2023Q1 dei Entity Address Country
EntityAddressCountry
IL
CY2023Q1 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
3903212
CY2023Q1 dei City Area Code
CityAreaCode
+972
CY2023Q1 dei Local Phone Number
LocalPhoneNumber
4-8124101
CY2023Q1 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
NV
CY2023Q1 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
47-3052410
CY2023Q1 dei Entity Address Address Line1
EntityAddressAddressLine1
1 Etgar Street
CY2023Q1 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2023Q1 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2023Q1 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2023Q1 dei Entity Small Business
EntitySmallBusiness
true
CY2023Q1 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2023Q1 dei Entity Shell Company
EntityShellCompany
false
CY2023Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
54218813 shares
CY2023Q1 us-gaap Cash
Cash
2621000 usd
CY2022Q4 us-gaap Cash
Cash
2849000 usd
CY2023Q1 us-gaap Other Assets Current
OtherAssetsCurrent
167000 usd
CY2022Q4 us-gaap Other Assets Current
OtherAssetsCurrent
86000 usd
CY2023Q1 us-gaap Assets Current
AssetsCurrent
2788000 usd
CY2022Q4 us-gaap Assets Current
AssetsCurrent
2935000 usd
CY2023Q1 us-gaap Deferred Costs Leasing Net Noncurrent
DeferredCostsLeasingNetNoncurrent
152000 usd
CY2022Q4 us-gaap Deferred Costs Leasing Net Noncurrent
DeferredCostsLeasingNetNoncurrent
15000 usd
CY2023Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
56000 usd
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
42000 usd
CY2023Q1 us-gaap Assets
Assets
2996000 usd
CY2022Q4 us-gaap Assets
Assets
2992000 usd
CY2023Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
87000 usd
CY2022Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
85000 usd
CY2023Q1 usdr Other Accounts Liabilities Current
OtherAccountsLiabilitiesCurrent
236000 usd
CY2022Q4 usdr Other Accounts Liabilities Current
OtherAccountsLiabilitiesCurrent
176000 usd
CY2023Q1 us-gaap Liabilities Current
LiabilitiesCurrent
323000 usd
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
261000 usd
CY2023Q1 usdr Stockholders Loans Noncurrent
StockholdersLoansNoncurrent
307000 usd
CY2022Q4 usdr Stockholders Loans Noncurrent
StockholdersLoansNoncurrent
305000 usd
CY2023Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
80000 usd
CY2023Q1 us-gaap Liabilities
Liabilities
710000 usd
CY2022Q4 us-gaap Liabilities
Liabilities
566000 usd
CY2023Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2023Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2023Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
54218813 shares
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
54218813 shares
CY2023Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
54218813 shares
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
54218813 shares
CY2023Q1 us-gaap Common Stock Value
CommonStockValue
5000 usd
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
5000 usd
CY2023Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
11476000 usd
CY2022Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
11437000 usd
CY2023Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-9195000 usd
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-9016000 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
2286000 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
2426000 usd
CY2023Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
2996000 usd
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
2992000 usd
CY2022Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
6000 usd
CY2023Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
202000 usd
CY2022Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
331000 usd
CY2023Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-202000 usd
CY2022Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-337000 usd
CY2023Q1 usdr Financing Incomeexpense Net
FinancingIncomeexpenseNet
23000 usd
CY2022Q1 usdr Financing Incomeexpense Net
FinancingIncomeexpenseNet
-32000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-179000 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-369000 usd
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0
CY2022Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.01
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
54486313 shares
CY2022Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
54034369 shares
CY2022Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
2426000 usd
CY2023Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
39000 usd
CY2023Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-179000 usd
CY2023Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
2286000 usd
CY2021Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
3101000 usd
CY2022Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
180000 usd
CY2022Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-369000 usd
CY2022Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-2912000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-179000 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-369000 usd
CY2023Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
2000 usd
CY2023Q1 us-gaap Share Based Compensation
ShareBasedCompensation
39000 usd
CY2022Q1 us-gaap Share Based Compensation
ShareBasedCompensation
169000 usd
CY2023Q1 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
-2000 usd
CY2022Q1 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
-2000 usd
CY2023Q1 usdr Increase Decrease In Operating Lease Right Of Use Asset
IncreaseDecreaseInOperatingLeaseRightOfUseAsset
13000 usd
CY2023Q1 us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
7000 usd
CY2023Q1 us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
76000 usd
CY2022Q1 us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
-23000 usd
CY2023Q1 us-gaap Increase Decrease In Notes Payable Current
IncreaseDecreaseInNotesPayableCurrent
2000 usd
CY2022Q1 us-gaap Increase Decrease In Notes Payable Current
IncreaseDecreaseInNotesPayableCurrent
1000 usd
CY2023Q1 us-gaap Increase Decrease In Other Accounts Payable
IncreaseDecreaseInOtherAccountsPayable
7000 usd
CY2022Q1 us-gaap Increase Decrease In Other Accounts Payable
IncreaseDecreaseInOtherAccountsPayable
41000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-209000 usd
CY2022Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-133000 usd
CY2023Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
16000 usd
CY2022Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
12000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-16000 usd
CY2022Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-12000 usd
CY2023Q1 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Disposal Group Including Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsDisposalGroupIncludingDiscontinuedOperations
-3000 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-228000 usd
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-145000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
2849000 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
3560000 usd
CY2023Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
2621000 usd
CY2022Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
3415000 usd
CY2022Q1 us-gaap Stock Issued1
StockIssued1
11000 usd
CY2023Q1 usdr Initial Recognition Of Operating Lease Rightofuse Assets
InitialRecognitionOfOperatingLeaseRightofuseAssets
146000 usd
CY2023Q1 usdr Initial Recognition Of Operating Lease Liability
InitialRecognitionOfOperatingLeaseLiability
146000 usd
CY2020Q2 us-gaap Temporary Equity Redemption Price Per Share
TemporaryEquityRedemptionPricePerShare
0.0001
CY2023Q1 us-gaap Use Of Estimates
UseOfEstimates
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><b>Use of Estimates</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The preparation of unaudited condensed consolidated financial statements in conformity with accounting principles generally accepted in the United States requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, certain revenues and expenses, and disclosure of contingent assets and liabilities as of the date of the financial statements. Actual results could differ from those estimates. As applicable to these unaudited condensed financial statements, the most significant estimates and assumptions relate to the share based compensation.</p>
CY2022Q2 us-gaap Lessee Operating Lease Renewal Term
LesseeOperatingLeaseRenewalTerm
P3Y
CY2022Q2 us-gaap Operating Lease Payments
OperatingLeasePayments
4600000 usd
CY2022Q2 us-gaap Operating Lease Payments Use
OperatingLeasePaymentsUse
4800000 usd
CY2022Q2 us-gaap Loans And Leases Receivable Commitments Fixed Rates
LoansAndLeasesReceivableCommitmentsFixedRates
15000 usd
CY2023Q1 us-gaap Operating Lease Expense
OperatingLeaseExpense
4000 usd
CY2023Q1 us-gaap Other Operating Activities Cash Flow Statement
OtherOperatingActivitiesCashFlowStatement
10000 usd
CY2023Q1 us-gaap Operating Leases Income Statement Initial Direct Costs
OperatingLeasesIncomeStatementInitialDirectCosts
146000 usd
CY2023Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
138000 usd
CY2023Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
52000 usd
CY2023Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
80000 usd
CY2023Q1 us-gaap Operating Lease Liability
OperatingLeaseLiability
132000 usd
CY2023Q1 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P2Y9M18D
CY2023Q1 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0875 pure
CY2023Q1 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
41000 usd
CY2023Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
55000 usd
CY2023Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
52000 usd
CY2023Q1 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
148000 usd
CY2023Q1 us-gaap Receivable With Imputed Interest Net Amount
ReceivableWithImputedInterestNetAmount
16000 usd
CY2023Q1 us-gaap Short Term Lease Commitment Amount
ShortTermLeaseCommitmentAmount
132000 usd
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
2426812 shares
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
0.81
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
2426812 shares
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
0.81
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
1499592 shares
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
0.88
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue
54000 usd
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Period Increase Decrease Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingPeriodIncreaseDecreaseWeightedAverageExercisePrice
0.121
CY2023Q1 us-gaap Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Outstanding Options
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions
2426812 shares
CY2023Q1 us-gaap Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Remaining Contractual Term2
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2
P4Y10D
CY2023Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares
1499592 shares
CY2022Q1 us-gaap Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Outstanding Options
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions
2426812 shares
CY2022Q1 us-gaap Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Remaining Contractual Term2
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2
P4Y3M10D
CY2022Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares
1387092 shares
CY2023Q1 us-gaap Allocated Share Based Compensation Expense Net Of Tax
AllocatedShareBasedCompensationExpenseNetOfTax
39000 usd
CY2023Q1 usdr Directors Compensation
DirectorsCompensation
107000 usd
CY2022Q1 usdr Directors Compensation
DirectorsCompensation
152000 usd
CY2023Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
18000 usd
CY2022Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
63000 usd
CY2023Q1 us-gaap Payments Of Financing Costs
PaymentsOfFinancingCosts
2000 usd
CY2022Q1 us-gaap Payments Of Financing Costs
PaymentsOfFinancingCosts
2000 usd
CY2023Q1 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
43000 usd
CY2022Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
35000 usd
CY2023Q1 us-gaap Loans Payable
LoansPayable
307000 usd
CY2022Q4 us-gaap Loans Payable
LoansPayable
305000 usd
CY2023Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
usd
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.00
CY2022Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
54034369 shares
CY2022Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
usd
CY2022Q1 usdr Increase Decrease In Operating Lease Right Of Use Asset
IncreaseDecreaseInOperatingLeaseRightOfUseAsset
usd
CY2022Q1 us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
usd
CY2022Q1 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Disposal Group Including Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsDisposalGroupIncludingDiscontinuedOperations
usd
CY2023Q1 us-gaap Stock Issued1
StockIssued1
usd
CY2022Q1 usdr Initial Recognition Of Operating Lease Rightofuse Assets
InitialRecognitionOfOperatingLeaseRightofuseAssets
usd
CY2022Q1 usdr Initial Recognition Of Operating Lease Liability
InitialRecognitionOfOperatingLeaseLiability
usd
CY2022Q1 us-gaap Operating Lease Expense
OperatingLeaseExpense
usd
CY2022Q1 us-gaap Other Operating Activities Cash Flow Statement
OtherOperatingActivitiesCashFlowStatement
usd
CY2022Q1 us-gaap Operating Leases Income Statement Initial Direct Costs
OperatingLeasesIncomeStatementInitialDirectCosts
usd
CY2022Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
usd
CY2022Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
usd
CY2022Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
usd
CY2022Q1 us-gaap Operating Lease Liability
OperatingLeaseLiability
usd
CY2022Q1 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
CY2022Q1 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
pure
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
shares
CY2023Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
CY2023Q1 usdr Share Based Compensation Arrangement By Share Based Payment Award Options Exercise In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExerciseInPeriod
shares
CY2023Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
shares
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
CY2022Q1 usdr Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRange
CY2023Q1 dei Amendment Flag
AmendmentFlag
false
CY2023Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2023Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2023Q1 dei Entity Central Index Key
EntityCentralIndexKey
0001638911

Files In Submission

Name View Source Status
FilingSummary.xml Edgar Link unprocessable
0001213900-23-037670-index-headers.html Edgar Link pending
0001213900-23-037670-index.html Edgar Link pending
0001213900-23-037670.txt Edgar Link pending
0001213900-23-037670-xbrl.zip Edgar Link pending
f10q0323ex31-1_uasdrone.htm Edgar Link pending
f10q0323ex31-2_uasdrone.htm Edgar Link pending
f10q0323ex32-1_uasdrone.htm Edgar Link pending
f10q0323ex32-2_uasdrone.htm Edgar Link pending
f10q0323_uasdrone.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
f10q0323_uasdrone_htm.xml Edgar Link completed
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
usdr-20230331.xsd Edgar Link pending
usdr-20230331_cal.xml Edgar Link unprocessable
usdr-20230331_lab.xml Edgar Link unprocessable
usdr-20230331_def.xml Edgar Link unprocessable
usdr-20230331_pre.xml Edgar Link unprocessable